Vasculitis in Children: A Diagnostic Challenge

Current Problems in Pediatric and Adolescent Health Care

Volumn 27, Issue 8, 1997, Pages 309-318

  Cuttica, Rubén J ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLACTOID PURPURA; AORTA ARCH SYNDROME; CHILD; FEMALE; HUMAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NOMENCLATURE; ONSET AGE; PATHOPHYSIOLOGY; POLYARTERITIS NODOSA; REVIEW; VASCULITIS;

AGE OF ONSET; CHILD; FEMALE; HUMANS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYARTERITIS NODOSA; PURPURA, SCHOENLEIN-HENOCH; TAKAYASU'S ARTERITIS; TERMINOLOGY; VASCULITIS;

EID: 0031217634     PISSN: 15385442     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0045-9380(97)80022-9     Document Type: Article

References (17)

1. Jennette JC, Falk R, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: proposal of an International Consensus Conference. Arthritis Rheum 1994;37:187-92.
2. Lie TJ. Nomenclature and classification of vasculitis: plus ça change, plus c'est la même chose. Arthritis Rheum 1994;37: 181-6.
3. Athreya BH. Vasculitis in children. Pediatr Clin North Am 1995;42:1239-61.
4. American Heart Association Committee on Rheumatic Fever. Diagnostic guidelines for Kawasaki disease. JAMA 1990;44:1218-9.
5. Yanagawa H, Nakamura Y, Yashiro M, Kawasaki T, Kato H. Epidemiology of Kawasaki disease in Japan. Japan Kawasaki Disease Research Center, Tokyo. May 1995.
6. Yanagawa H. Comments on global epidemiology of Kawasaki disease. Proceedings of the 5th Kawasaki disease symposium. Fukuoka, Japan, May 22-25, 1995.
7. Leung DYM, Cody Meissner H, Fulton DR, Quimby F, Schlievert PM. Superantigens in Kawasaki syndrome. Clin Immunol Immunopathol 1995;77:119-26.
8. Kotzin BL, Leung DYM, Kappler J, Marrack P. Superantigens and human disease. Adv Immunol 1993;54:99-166.
9. Nash MC, Shah V, Reader JA, Dillon MJ. Antineutrophil cytoplasmic antibodies and anti-endothelial cell antibodies are not increased in Kawasaki disease. Br J Rheum 1995;34:882-7.
10. Lightfoot RW, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990;33:1088-93.
11. Kallenberg CGM. Autoantibodies in vasculitis: current perspectives. Clin Exp Rheumatol 1993;11:355-60.
12. Jayne DR, Gaskin G, Pusey CD, Lockwood CM. ANCA and predicting relapse in systemic vasculitis. QJM 1995;88:127-33.
13. Targan SR, Landers C, Vidrich A, Czaja AJ. High titer antineutrophil cytoplasmic antibodies in type 1 autoimmune hepatitis. Gastroenterology 1995;108:1159-66.
14. Lo SK, Fleming KA, Chapman RW. A 2-year follow-up study of anti-neutrophil antibody in primary sclerosing cholangitis: relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment. J Hepatol 1994;21: 974-8.
15. Gross WL, Csernok E. Immunodiagnostic andpathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis. Curr Opin Rheumatol 1995;7:11-9.
16. Dillon MJ, Ansell BM. Vasculitis in children and adolescents. Rheum Dis Clin North Am 1995;21:1115-36.
17. Martini A. Behçet's disease and Takayasu's disease in children. Curr Opin Rheumatol 1995;7:449-54.